Status:
RECRUITING
Bio Impedance Monitoring as a Tool to Assess Fluid Status in the Pediatric Surgical Patient? (PedFluid Study)
Lead Sponsor:
University Hospital, Antwerp
Conditions:
Fluid and Electrolyte Imbalance
Body Weight Changes
Eligibility:
All Genders
1-16 years
Phase:
NA
Brief Summary
The baseline infusion rate during surgery for pediatric patients still is the 'Holliday and Segar' rule (also known as the 4/2/1 rule) The question arises if this rule is not outdated, since it was ca...
Detailed Description
The Body Composition Monitor (BCM, Fresenius Medical Care, Germany) is the first device that determines individual fluid status and body composition in an easy and objective way. The technology uses b...
Eligibility Criteria
Inclusion
- Scheduled for elective surgery or investigation under general anesthesia
- Day care or inpatient hospitalisation
Exclusion
- If sedation is needed instead of general anesthesia
- Critically ill patients for urgent surgery
- Patients who cannot lie still for performing correct measurements on the bio impedance monitor
- No informed consent obtained
Key Trial Info
Start Date :
April 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05220709
Start Date
April 5 2022
End Date
May 31 2026
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp University Hospital
Edegem, Antwerp, Belgium, 2650